COMPARE · Data as of October 9, 2026

BLDR vs ECG

Verdict: Side-by-side breakdown using the Bull Rankings model. BLDR scored 26.9, ECG scored 72.0 — ECG leads.
Compare another set
BLDR
Builders FirstSource, Inc.
Building Products & Equipment · Quality-Growth
26.9
$52.85 · $5.7B
fundamentals as of
Score gap
45.1
ECG leads
ECG
Everus Construction Group, Inc.
Engineering & Construction · Quality-Growth
72
$122.44 · $6.2B
fundamentals as of
  • CheapestECG24.6x
  • Fastest growthECG+30.5%
  • Strongest balance sheetECG0.47
  • Highest qualityECG77 / 100
  • Largest discount to fair valueBLDR-1%
THE BULL RANKINGS SCORECARD26.9/ 100 · BULL SCOREPEER MEDIANQUALITY52.9GROWTH12.4VALUE29.7
THE BULL RANKINGS SCORECARD72.0/ 100 · BULL SCOREPEER MEDIANQUALITY77.0GROWTH89.5VALUE73.3
BLDRECGQuality52.977.0Growth12.489.5Value29.773.3
cheap & fastrevenue growth →← cheaper (lower multiple)-17%41%19x63xBLDRECG

Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.

FCFBLDR$639mECG$250m
RevBLDR-7.4%ECG+30.5%
D/EBLDR1.31ECG0.47
P/EBLDR57.4xECG24.6x
BLDR
stronger →← stronger
ECG
53
Qualityreturns · margins · balance sheet
77
12
Growthrevenue & earnings expansion
90
30
Valuevaluation vs sector peers
73
ECG is stronger on 3 of 3 pillars.
BLDR
ECG
$639mC+
FCF
$250mC
-7.4%D
Rev
+30.5%A
1.31C
D/E
0.47B+
57.4xD
P/E
24.6xB
—
PEG
1.33B
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
BLDR
ECG
1% below
Price vs fair valuelower is cheaper
23% above
~-2%/yr
Growth the price impliesyr-1 FCF growth, fading to 4% · lower = less priced in
~17%/yr
+13%
1-yr DCF upside
-32%
+1%
5-yr DCF upside
-18%
-13%
10-yr DCF upside
+7%
These two disagree on this pair: the Value pillar ranks cheapness against sector peers, while price-vs-fair-value is an absolute read. A name can be the better value in its sector and still the dearer one on cash flows.
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
BLDR
Why this score
  • Buying back stock
  • Durable high returns
ECG
Why this score
  • Durable high returns
  • Short track record
BLDRBuilders FirstSource, Inc.
Building Products & Equipment · $52.85 · beta 1.45
Why now
Building Products & Equipment · market cap $5.7b. Down 60% from 52-week high of $131.50 — deep drawdown territory. Revenue -7% — in contraction; any catalyst that reverses this triggers re-rating. 22 sell-side analysts rate this a Buy with a mean 1-yr target of $76.05 (implying +44% upside).
Moat
Free cash flow runs well ahead of reported net income, mostly because of depreciation and amortization ($597m) — non-cash charges that hold down reported earnings while cash generation stays strong.
Risk
Trailing P/E 57.4x prices in sustained high growth — any quarter that disappoints triggers sharp re-rating. Revenue contracting -7% — the operational turn is not yet visible in the top line. Down 60% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up.
ECGEverus Construction Group, Inc.
Engineering & Construction · $122.44
Why now
Engineering & Construction · market cap $6.2b. Down 29% from 52-week high of $171.58 — deep drawdown territory. Revenue growing +31% — in hypergrowth territory. 6 sell-side analysts rate this a Buy with a mean 1-yr target of $176.00 (implying +44% upside).
Moat
ROE 33% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which. FCF converts 98% of net income — earnings translate cleanly into cash.
Risk
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.

Where BLDR and ECG diverge

On the headline score the gap is 45.1 points in favor of ECG. The widest single difference is Growth, where ECG leads by 77.1 points.

Pillars run 0–100. Value is judged against each company's own sector, so a Value score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.

Common questions

Is ECG or BLDR the better stock?

ECG scores higher: ECG 72.0, BLDR 26.9 out of 100 on the Bull Rankings quality-growth score, which blends business quality, growth and valuation into one number. A higher score means a stronger business at a more reasonable price — it is not a price target or a recommendation.

Where do ECG and BLDR differ most?

The widest gap is growth, where ECG leads by 77 points on the 0–100 pillar scale. ECG leads all three pillars, so the gap is broad rather than a single-measure difference.

How are ECG and BLDR scored?

Each carries the same 0–100 quality-growth score used everywhere on the site, built from three pillars — quality (profitability and returns on capital), growth (revenue and earnings), and value (what you pay for them) — combined as a geometric mean, so a weak pillar cannot be papered over by a strong one.

How current is this comparison?

The whole universe is re-scored every trading day after the US market close, so the scores and fundamentals here reflect the latest published edition.